Randomized, Controlled, Single-blind Exploratory Study of the Efficacy and Safety of Wrist and Ankle Acupuncture Intervention on Nausea, Vomiting and Pain After Sleeve Gastric Surgery in Women
1 other identifier
observational
66
1 country
1
Brief Summary
PONV is the most common clinical presentation after surgical procedures beyond pain. A retrospective study of our center found that the postoperative incidence of LSG was 77.4%. PONV can not only cause postoperative discomfort, but also cause serious complications such as disturbance water and electrolyte balance, wound splitting, incisional hernia, and even residual gastric leakage and aspiration pneumonia, resulting in prolonged hospital stay and increased medical costs. Wrist and ankle acupuncture is a special kind of acupuncture therapy. Through subcutaneous stimulation, the electrical signal is fed back along the nerve fiber into the cerebral cortex, without dialectical treatment, and only needs the appropriate symptoms and signs of the patient. Although only in the wrist and ankle, it can solve a series of problems in the whole body, especially nausea, vomiting and pain symptoms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 23, 2023
CompletedFirst Submitted
Initial submission to the registry
April 10, 2023
CompletedFirst Posted
Study publicly available on registry
May 24, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 23, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 15, 2025
CompletedMay 24, 2023
May 1, 2023
1 year
April 10, 2023
May 15, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Change from Baseline pain at 24 hours after surgery
Using Visual Analogue Scale of Pain (VASP), a score 0 represents no significant pain in the past time period; a score 1-3 represents mild pain that does not affect sleep; a score 4-6 means moderate pain that slightly affects sleep; and a score 7-10 represents severe pain leading to poor sleep or painful awakening from sleep
Change from Baseline pain at 24 hours after surgery
Change from Baseline nausea and vomitting at 24 hours after surgery
PONV was scored using the Visual Nausea analog core (Visual Analog Scale of Nausea, VASN).0 represents no significant nausea and vomiting in the past period; 1-3 represents mild PONV does not affect sleep; 4-6 represents moderate PONV slightly affects sleep; and 7-10 represents severe PONV causes failed to sleep. The simplified PONV impact scale was used while performing the VASN score. The assessment of PONV severity was performed to ensure the objectivity of the outcome measures evaluation. The simplified questionnaire consisted of 2 questions, each with the corresponding score, scoring 5 points defined as clinically significant PONV
Change from Baseline nausea and vomitting at 24 hours after surgery
Secondary Outcomes (4)
Gastrointestinal function
Before discharge
drug used
Before discharge
Quality of life situation before discharge
Before discharge
complication
perioperative period
Study Arms (2)
control group
Intervention group
Interventions
Patients in the intervention arm started the wrist and ankle acupuncture treatment 1 day before the surgery. Take up and down 1,2 area as a needle point, use hua tuo brand sterile acupuncture needle (specification: 0.25mm 25mm), into the skin disinfection into the needle, keep 30 subcutaneous needle and skin, when the operator under the needle, patients without acid swelling, pain, close to the skin dermis, to about 1.5 inches, give tape fixed 24h, left under the skin, until postoperative 3 day.
Eligibility Criteria
Female patient undergoing sleeve gastric surgery in the weight loss center of the First Affiliated Hospital of Jinan University
You may qualify if:
- In accordance with the Guidelines for Surgical Treatment of Obesity and Type 2 Diabetes in China (2019 edition);
- ASA grades II-III; Age: 18-65 years old;
- Denial of smoking history;
- Denied any history of motion sickness or PONV;
- Female patients proposed to undergo laparoscopic sleeve gastrectomy under elective general anesthesia;
- Voluntary attended and signed informed consent.
You may not qualify if:
- With known drug allergies related to this study;
- Severe heart, respiratory, renal or liver diseases, and coagulation disorders;
- Psychiatric or neurological disorders;
- difficulties in communication;
- Premedication or premedical conditions limits target assessment, including use of antiemetics, opioids or corticosteroids (excluding anesthetic medication);
- Gastroesophageal reflux (GRED), clinically assessed as severe GRED or preoperative gastroscopy indicating grade B of oesophagitis or above;
- Patients undergoing combined cholecystectomy and gynecological surgery during the operation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- LILIAN GAOlead
Study Sites (1)
The First Affiliated Hospital of Jinan University
Guangdong, Guangzhou, 510600, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- nurse
Study Record Dates
First Submitted
April 10, 2023
First Posted
May 24, 2023
Study Start
March 23, 2023
Primary Completion
March 23, 2024
Study Completion
April 15, 2025
Last Updated
May 24, 2023
Record last verified: 2023-05